The latest study by Dr. Sandra Dial from the Research Institute of the MUHC, McGill University, and Attending Staff in the Intensive Care Unit at the Jewish General Hospital, questions the assumption held by a vast majority of medical professionals that Clostridium difficile (C.difficile) infections are essentially always preceded by antibiotic use. This finding could have a major impact on how patients with diarrhea are evaluated upon their admission to the hospital. This study will appear in the October 6 issue of the Canadian Medical Association Journal (CMAJ).
The researchers analyzed only C. difficile infections acquired outside the hospital by patients aged 65 or older, and serious enough to require a hospitalization. Patients with hospital-acquired C.difficile infections were excluded because of the increased risk of infection and antibiotic use in the hospital environment.
Their results show that 53% of the patients studied had not been exposed to antibiotics during the 45 days preceding their C.difficile-related hospitalisation. A rate that decreased to 46% when the pre-hospitalization timeframe analysed was extended to 90 days. "These figures show that approximately 50% of community-acquired C. difficile infections are not related to antibiotic use," explained Dr. Dial. "While antibiotic use indeed plays an important role, other factors are likely to also be important. But we still need to determine what these other risk factors are."
More precisely, this study demonstrates that the highest risk of C. difficile infection due to antibiotic use occurs during the 30 days following treatment. According to Dr. Dial, "Beyond the 45-day period following treatment, the risk declines significantly".
"We believe that all patients suffering from diarrhea, particularly if severe enough to require a hospital visit, should be tested for C.difficile at their arrival in the hospital. Right now, testing is mainly done on patients who have taken antibiotics, which probably means that not everyone is receiving a correct diagnosis," warned Dr. Dial.
Source: McGill University Health Centre
Related stories:
Hospitals could be fined millions of pounds even if they reduce infection risk
NHS Hospital Trusts that are successful in reducing Clostridium difficile risks in line with government targets still have a 50% chance of paying a financial penalty every year, and around a 95% chance of being fined over three years, warn researchers on bmj.com today.
Report documents widespread presence of C. diff. bacteria in hospitals
A nasty germ that wreaks havoc in people's guts is infecting hospital patients at rates much higher than previously estimated, according to a report released Tuesday.
'Superbugs' on the rise in Canadian hospitals
Although infection control has been substantially ramped up in Canadian hospitals since the SARS crisis of 2003, the number of resistant bacterial infections post-SARS have multiplied even faster, a new Queen's University study shows.
Is re-emerging superbug the next MRSA?
Dr. Ed Corboy had no idea what was afflicting his 80-year-old mother, Joan Corboy. All he knew for certain was that since being treated for what was a routine diarrheal infection, she seemed to be wasting away and none of her doctors or other health specialists could explain why.
Breakthrough in the fight against deadly superbug
(PhysOrg.com) -- The week the government's chief medical officer for England, Sir Liam Donaldson, has announced that the NHS aims to create immunisation against two of the most common superbugs, MRSA and Clostridium difficile, within the next decade. But a research team led by University of Sunderland scientists has made a major breakthrough in the fight against a deadly hospital infection which kills tens of thousands of people every year, and it will be available within the next year.
Online courses boost infection control skills that could prove vital in a pandemic
Online courses are helping staff to develop the skills they need to tackle hospital-acquired infections, such as MRSA and
C.difficile, and this expertise could also prove vital in a pandemic, according to a study published in the latest issue of the UK-based
Journal of Advanced Nursing.
Less hype and more research needed into new 'superbug,' say experts
Recent tabloid hype over the "newly emerging superbug", Stenotrophomonas maltophilia, is misplaced, say experts in this week's issue of the
BMJ.
UV lotion lights the way to cleaner facilities
A team of Canadian scientists using a lotion which glows under ultraviolet light have shown that up to a third of patient toilets are not properly cleaned. Their findings, published in BioMed Central’s journal,
BMC Infectious Diseases, also show that spores from the nasty bacteria Clostridium difficile (C. difficile) linger in the loo even when it has been thoroughly wiped down.